Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Adrenergic signaling in cardiomyocytes
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Adrenergic signaling in cardiomyocytes
| Azilsartan medoxomil | 066 [1] 66 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Adrenergic signaling in cardiomyocytes
| Buloxibutid | 085 [1] 85 💬7. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Adrenergic signaling in cardiomyocytes
| Buloxibutid | 085 [1] 85 💬7. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Adrenergic signaling in cardiomyocytes
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Adrenergic signaling in cardiomyocytes
| Irbesartan | 066 [4] 66, 167, 168, 222 💬10. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬11. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬11. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Adrenergic signaling in cardiomyocytes
| Sparsentan | 066 [3] 66, 218, 222 💬13. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Adrenergic signaling in cardiomyocytes
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Adrenergic signaling in cardiomyocytes
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬15. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||
| 16 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 17 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 18 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬AGE-RAGE signaling pathway in diabetic complications
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬16. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 19 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 20 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 21 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬AGE-RAGE signaling pathway in diabetic complications
| Azilsartan medoxomil | 066 [1] 66 💬19. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 22 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬AGE-RAGE signaling pathway in diabetic complications
| Buloxibutid | 085 [1] 85 💬22. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 23 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬AGE-RAGE signaling pathway in diabetic complications
| Buloxibutid | 085 [1] 85 💬22. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 24 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 25 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Irbesartan | 066 [4] 66, 167, 168, 222 💬25. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 26 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬26. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 27 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬26. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 28 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬AGE-RAGE signaling pathway in diabetic complications
| Sparsentan | 066 [3] 66, 218, 222 💬28. AGE-RAGE signaling pathway in diabetic complications |
||||||||||||||||||||||||||||||||||||||||||||||
| 29 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬AGE-RAGE signaling pathway in diabetic complications
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 30 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬30. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Aldosterone synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬31. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Aldosterone synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬34. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Aldosterone synthesis and secretion
| Buloxibutid | 085 [1] 85 💬37. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Aldosterone synthesis and secretion
| Buloxibutid | 085 [1] 85 💬37. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Aldosterone synthesis and secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Aldosterone synthesis and secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬40. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬41. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬41. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Aldosterone synthesis and secretion
| Sparsentan | 066 [3] 66, 218, 222 💬43. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Aldosterone synthesis and secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Aldosterone synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Aldosterone synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬45. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Apelin signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬46. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Apelin signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬49. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Apelin signaling pathway
| Buloxibutid | 085 [1] 85 💬52. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Apelin signaling pathway
| Buloxibutid | 085 [1] 85 💬52. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Apelin signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Apelin signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬55. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬56. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Apelin signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬58. Apelin signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Apelin signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Apelin signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Apelin signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬60. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Calcium signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬61. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Calcium signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬64. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Calcium signaling pathway
| Buloxibutid | 085 [1] 85 💬67. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Calcium signaling pathway
| Buloxibutid | 085 [1] 85 💬67. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Calcium signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Calcium signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬70. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬71. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬71. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Calcium signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬73. Calcium signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Calcium signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Calcium signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Calcium signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬75. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 76 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 77 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 78 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬cGMP-PKG signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬76. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 79 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 80 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 81 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬cGMP-PKG signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬79. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 82 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬cGMP-PKG signaling pathway
| Buloxibutid | 085 [1] 85 💬82. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 83 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬cGMP-PKG signaling pathway
| Buloxibutid | 085 [1] 85 💬82. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 84 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬cGMP-PKG signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 85 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬cGMP-PKG signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬85. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 86 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬86. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 87 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬86. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 88 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬cGMP-PKG signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬88. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
| 89 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬cGMP-PKG signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 90 | cGMP-PKG signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬cGMP-PKG signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬90. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Coronavirus disease - COVID-19
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬91. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Coronavirus disease - COVID-19
| Azilsartan medoxomil | 066 [1] 66 💬94. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Coronavirus disease - COVID-19
| Buloxibutid | 085 [1] 85 💬97. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Coronavirus disease - COVID-19
| Buloxibutid | 085 [1] 85 💬97. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Coronavirus disease - COVID-19
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Coronavirus disease - COVID-19
| Irbesartan | 066 [4] 66, 167, 168, 222 💬100. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Coronavirus disease - COVID-19
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬101. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Coronavirus disease - COVID-19
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬101. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Coronavirus disease - COVID-19
| Sparsentan | 066 [3] 66, 218, 222 💬103. Coronavirus disease - COVID-19 |
||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Coronavirus disease - COVID-19
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Coronavirus disease - COVID-19 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Coronavirus disease - COVID-19
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬105. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Cortisol synthesis and secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬106. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Cortisol synthesis and secretion
| Azilsartan medoxomil | 066 [1] 66 💬109. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Cortisol synthesis and secretion
| Buloxibutid | 085 [1] 85 💬112. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Cortisol synthesis and secretion
| Buloxibutid | 085 [1] 85 💬112. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Cortisol synthesis and secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Cortisol synthesis and secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬115. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬116. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬116. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Cortisol synthesis and secretion
| Sparsentan | 066 [3] 66, 218, 222 💬118. Cortisol synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Cortisol synthesis and secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Cortisol synthesis and secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Cortisol synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬120. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Cushing syndrome
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬121. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Cushing syndrome
| Azilsartan medoxomil | 066 [1] 66 💬124. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Cushing syndrome
| Buloxibutid | 085 [1] 85 💬127. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Cushing syndrome
| Buloxibutid | 085 [1] 85 💬127. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Cushing syndrome
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Cushing syndrome
| Irbesartan | 066 [4] 66, 167, 168, 222 💬130. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬131. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬131. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Cushing syndrome
| Sparsentan | 066 [3] 66, 218, 222 💬133. Cushing syndrome |
||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Cushing syndrome
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Cushing syndrome 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Cushing syndrome
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬135. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Diabetic cardiomyopathy
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬136. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Diabetic cardiomyopathy
| Azilsartan medoxomil | 066 [1] 66 💬139. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Diabetic cardiomyopathy
| Buloxibutid | 085 [1] 85 💬142. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Diabetic cardiomyopathy
| Buloxibutid | 085 [1] 85 💬142. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Diabetic cardiomyopathy
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Diabetic cardiomyopathy
| Irbesartan | 066 [4] 66, 167, 168, 222 💬145. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬146. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬146. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Diabetic cardiomyopathy
| Sparsentan | 066 [3] 66, 218, 222 💬148. Diabetic cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Diabetic cardiomyopathy
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Diabetic cardiomyopathy 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Diabetic cardiomyopathy
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬150. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Hormone signaling
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬151. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Hormone signaling
| Azilsartan medoxomil | 066 [1] 66 💬154. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Hormone signaling
| Buloxibutid | 085 [1] 85 💬157. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Hormone signaling
| Buloxibutid | 085 [1] 85 💬157. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Hormone signaling
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Hormone signaling
| Irbesartan | 066 [4] 66, 167, 168, 222 💬160. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬161. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬161. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Hormone signaling
| Sparsentan | 066 [3] 66, 218, 222 💬163. Hormone signaling |
||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Hormone signaling
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Hormone signaling 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Hormone signaling
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬165. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Neuroactive ligand-receptor interaction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬166. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Neuroactive ligand-receptor interaction
| Azilsartan medoxomil | 066 [1] 66 💬169. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Neuroactive ligand-receptor interaction
| Buloxibutid | 085 [1] 85 💬172. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Neuroactive ligand-receptor interaction
| Buloxibutid | 085 [1] 85 💬172. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Neuroactive ligand-receptor interaction
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Neuroactive ligand-receptor interaction
| Irbesartan | 066 [4] 66, 167, 168, 222 💬175. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 176 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬176. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬176. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Neuroactive ligand-receptor interaction
| Sparsentan | 066 [3] 66, 218, 222 💬178. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Neuroactive ligand-receptor interaction
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Neuroactive ligand-receptor interaction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Neuroactive ligand-receptor interaction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬180. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 183 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Pathways in cancer
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 184 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 186 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Pathways in cancer
| Azilsartan medoxomil | 066 [1] 66 💬184. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Pathways in cancer
| Buloxibutid | 085 [1] 85 💬187. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Pathways in cancer
| Buloxibutid | 085 [1] 85 💬187. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 189 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Pathways in cancer
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 190 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Pathways in cancer
| Irbesartan | 066 [4] 66, 167, 168, 222 💬190. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 191 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬191. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 192 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬191. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 193 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Pathways in cancer
| Sparsentan | 066 [3] 66, 218, 222 💬193. Pathways in cancer |
||||||||||||||||||||||||||||||||||||||||||||||
| 194 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Pathways in cancer
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 195 | Pathways in cancer 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Pathways in cancer
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬195. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||
| 196 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 197 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 198 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Phospholipase D signaling pathway
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬196. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 199 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 200 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 201 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Phospholipase D signaling pathway
| Azilsartan medoxomil | 066 [1] 66 💬199. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 202 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Phospholipase D signaling pathway
| Buloxibutid | 085 [1] 85 💬202. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 203 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Phospholipase D signaling pathway
| Buloxibutid | 085 [1] 85 💬202. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 204 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Phospholipase D signaling pathway
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 205 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Phospholipase D signaling pathway
| Irbesartan | 066 [4] 66, 167, 168, 222 💬205. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 206 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬206. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 207 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬206. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 208 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Phospholipase D signaling pathway
| Sparsentan | 066 [3] 66, 218, 222 💬208. Phospholipase D signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||
| 209 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Phospholipase D signaling pathway
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 210 | Phospholipase D signaling pathway 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Phospholipase D signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬210. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||
| 211 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 212 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 213 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Renin secretion
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬211. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 214 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 215 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 216 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Renin secretion
| Azilsartan medoxomil | 066 [1] 66 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 217 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Renin secretion
| Buloxibutid | 085 [1] 85 💬217. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 218 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Renin secretion
| Buloxibutid | 085 [1] 85 💬217. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 219 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Renin secretion
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 220 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Renin secretion
| Irbesartan | 066 [4] 66, 167, 168, 222 💬220. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 221 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬221. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 222 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬221. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 223 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Renin secretion
| Sparsentan | 066 [3] 66, 218, 222 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 224 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Renin secretion
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 225 | Renin secretion 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Renin secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬225. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||
| 226 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 227 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 228 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Renin-angiotensin system
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬226. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 229 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 230 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 231 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Renin-angiotensin system
| Azilsartan medoxomil | 066 [1] 66 💬229. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 232 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Renin-angiotensin system
| Buloxibutid | 085 [1] 85 💬232. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 233 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Renin-angiotensin system
| Buloxibutid | 085 [1] 85 💬232. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 234 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Renin-angiotensin system
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 235 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Renin-angiotensin system
| Irbesartan | 066 [4] 66, 167, 168, 222 💬235. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 236 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬236. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 237 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬236. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 238 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Renin-angiotensin system
| Sparsentan | 066 [3] 66, 218, 222 💬238. Renin-angiotensin system |
||||||||||||||||||||||||||||||||||||||||||||||
| 239 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Renin-angiotensin system
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 240 | Renin-angiotensin system 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Renin-angiotensin system
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬240. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||
| 241 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 242 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II Angiotensin II 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 243 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Angiotensin II acetate Angiotensin II acetate 💬Vascular smooth muscle contraction
| Angiotensin II | 017 [7] 17, 46, 49, 66, 218, 222, 224 💬241. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 244 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan medoxomil Azilsartan medoxomil 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 245 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan Azilsartan 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 246 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Azilsartan kamedoxomil Azilsartan kamedoxomil 💬Vascular smooth muscle contraction
| Azilsartan medoxomil | 066 [1] 66 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 247 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid Buloxibutid 💬Vascular smooth muscle contraction
| Buloxibutid | 085 [1] 85 💬247. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 248 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Buloxibutid sodium Buloxibutid sodium 💬Vascular smooth muscle contraction
| Buloxibutid | 085 [1] 85 💬247. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 249 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Candesartan Candesartan 💬Vascular smooth muscle contraction
| Candesartan | 058 [2] 58, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 250 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Vascular smooth muscle contraction
| Irbesartan | 066 [4] 66, 167, 168, 222 💬250. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 251 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬251. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 252 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬251. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||
| 253 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Sparsentan Sparsentan 💬Vascular smooth muscle contraction
| Sparsentan | 066 [3] 66, 218, 222 💬253. Vascular smooth muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||
| 254 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Telmisartan Telmisartan 💬Vascular smooth muscle contraction
| Telmisartan | 066 [2] 66, 67 💬
|
||||||||||||||||||||||||||||||||||||||||||||||
| 255 | Vascular smooth muscle contraction 💬 1 gene, 9 drugs (DrugBank) and 26 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Vascular smooth muscle contraction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬255. Vascular smooth muscle contraction
|
Adrenergic signaling in cardiomyocytes
1 gene, 9 drugs (DrugBank) and 26 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 9 drugs (DrugBank) and 26 diseases
Aldosterone synthesis and secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Apelin signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Calcium signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
cGMP-PKG signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Coronavirus disease - COVID-19
1 gene, 9 drugs (DrugBank) and 26 diseases
Cortisol synthesis and secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Cushing syndrome
1 gene, 9 drugs (DrugBank) and 26 diseases
Diabetic cardiomyopathy
1 gene, 9 drugs (DrugBank) and 26 diseases
Hormone signaling
1 gene, 9 drugs (DrugBank) and 26 diseases
Neuroactive ligand-receptor interaction
1 gene, 9 drugs (DrugBank) and 26 diseases
Pathways in cancer
1 gene, 9 drugs (DrugBank) and 26 diseases
Phospholipase D signaling pathway
1 gene, 9 drugs (DrugBank) and 26 diseases
Renin secretion
1 gene, 9 drugs (DrugBank) and 26 diseases
Renin-angiotensin system
1 gene, 9 drugs (DrugBank) and 26 diseases
Vascular smooth muscle contraction
1 gene, 9 drugs (DrugBank) and 26 diseases
